Bellevue Group

Bellevue Group is a specialized Swiss asset manager with a core focus on the healthcare and biotechnology sectors. Through its primary subsidiary, Bellevue Asset Management, the group manages a variety of investment vehicles, most notably BB Biotech AG, which is one of the world's largest and most prominent investment companies dedicated to the biotechnology industry. The firm provides investment solutions across the entire healthcare spectrum, including small- and mid-cap biotech, medtech, healthcare services, and digital health. Bellevue is recognized for its deep sector expertise, employing teams of scientists and financial analysts to identify innovative companies with high growth potential. The group is listed on the SIX Swiss Exchange and serves both institutional and private clients globally. While not a drug developer itself, Bellevue Group is a critical player in the life sciences ecosystem as a major provider of capital to emerging and established biotech firms.